Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 1, 2012, Pages 79-85

  Ng, Tien M H ^a   Ackerbauer, Kimberly A ^a   Hyderi, Alifiya F ^a   Hshieh, Shenche ^a   Elkayam, Uri ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

acute heart failure; acute kidney injury; nesiritide; nitroglycerin; RIFLE criteria

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; HYPERTENSIVE AGENT; NESIRITIDE; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ADULT; AGED; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITROGLYCERIN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84856974205     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248411406441     Document Type: Article

References (21)

1. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R.. Cardiorenal syndrome. J Am Coll Cardiol. 2008 ; 52 (19). 1527-1539
2. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ.. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005 ; 293 (5). 572-580 (Pubitemid 40171239)
3. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006 ; 47 (10). 1987-1996
4. Cogan JJ, Humphreys MH, Carlson CJ, Benowitz NL, Rapaport E.. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure. Circulation. 1981 ; 64 (5). 973-976 (Pubitemid 11028094)
5. Leier CV.. Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol. 1988 ; 62 (8). 86E - 93E
6. Elkayam U, Akhter MW, Liu M, Hatamizadeh P, Barakat MN.. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography. JACC Cardiovasc Imaging. 2008 ; 1 (6). 765-771
7. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C.. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993 ; 76 (1). 91-96 (Pubitemid 23027559)
8. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004 ; 110 (12). 1620-1625 (Pubitemid 39297985)
9. Sackner-Bernstein JD, Skopicki HA, Aaronson KD.. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005 ; 111 (12). 1487-1491 (Pubitemid 40470642)
10. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 2000 ; 343 (4). 246-253 (Pubitemid 30490392)
11. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002 ; 287 (12). 1531-1540
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P.. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 ; 8 (4). R204 - R212
13. Hata N, Yokoyama S, Shinada T, et al. Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail. 2010 ; 12 (1). 32-37
14. Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation. 2007 ; 116 (11)(suppl). I134 - I138
15. Riter HG, Redfield MM, Burnett JC, Chen HH.. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. 2006 ; 47 (11). 2334-2335 (Pubitemid 43795074)
16. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol. 2007 ; 49 (6). 716-726 (Pubitemid 46205038)
17. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation. 2004 ; 109 (13). 1680-1685 (Pubitemid 38451727)
18. Gotsman I, Zwas D, Planer D, Admon D, Lotan C, Keren A.. The significance of serum urea and renal function in patients with heart failure. Medicine (Baltimore). 2010 ; 89 (4). 197-203
19. Klein L, Massie BM, Leimberger JD, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008 ; 1 (1). 25-33
20. Abraham WT.. Serum creatinine elevations in patients receiving nesiritide are related to starting dose. Circulation. 2005 ; 112 (17 suppl II). 589
21. Young JB, Cheng M, Mills RM.. Hemodynamics, diuretics, and nesiritide: a retrospective VMAC analysis. Clin Cardiol. 2009 ; 32 (9). 530-536